Mannkind (MNKD) Non-Current Deffered Revenue (2017 - 2026)

Mannkind's (MNKD) quarterly Non-Current Deffered Revenue came in at $38.9 million in Q1 2026, down 17.85% year-on-year from $47.4 million in Q1 2025, and down 2.68% on a QoQ basis from $40.0 million in Q4 2025.

Mannkind (MNKD) Non-Current Deffered Revenue (2017 - 2026) Analysis & Trends

Mannkind (MNKD) has 10 years of Non-Current Deffered Revenue data on file, last reported at $38.9 million in Q1 2026.

  • On a quarterly basis, Non-Current Deffered Revenue fell 17.85% year-over-year to $38.9 million in Q1 2026; TTM through Mar 2026 was $38.9 million, a 17.85% decrease from a year earlier, with the FY2025 full-year figure at $40.0 million, down 21.86% from the prior year.
  • Non-Current Deffered Revenue for Q1 2026 stood at $38.9 million, down from $40.0 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for MNKD reached as high as $69.8 million in Q4 2023 and fell as low as $1.2 million in Q1 2023.
  • Historically, Non-Current Deffered Revenue has averaged $46.8 million across 5 years, with a median of $47.4 million in 2025.
  • Across the five-year window, Non-Current Deffered Revenue slumped 95.41% in 2023 and surged 5545.08% in 2024, its largest moves.
  • Year by year, Non-Current Deffered Revenue stood at $37.7 million in 2022, then jumped by 85.21% to $69.8 million in 2023, then retreated by 26.7% to $51.2 million in 2024, then slipped by 21.86% to $40.0 million in 2025, then retreated by 2.68% to $38.9 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $38.9 million in Q1 2026, $40.0 million in Q4 2025, and $48.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Mannkind 1.20 Bn 1.07 Bn 82.66 Mn 38.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 38.91 Mn
Dec 31, 2025 39.98 Mn
Sep 30, 2025 48.19 Mn
Jun 30, 2025 45.47 Mn
Mar 31, 2025 47.36 Mn
Dec 31, 2024 51.16 Mn
Sep 30, 2024 65.15 Mn
Jun 30, 2024 66.12 Mn
Mar 31, 2024 67.74 Mn
Dec 31, 2023 69.79 Mn
Sep 30, 2023 69.47 Mn
Jun 30, 2023 60.25 Mn
Mar 31, 2023 1.20 Mn
Dec 31, 2022 37.68 Mn
Sep 30, 2022 32.00 Mn
Jun 30, 2022 29.76 Mn
Mar 31, 2022 26.12 Mn
Dec 31, 2021 19.54 Mn
Sep 30, 2021 1.55 Mn
Jun 30, 2021 1.59 Mn